(WCMH) – A pharmaceutical company voluntarily recalled blood pressure medication after detecting traces of a carcinogenic chemical.
Torrent Pharmaceuticals Limited announced the callback for two lots of losartan potassium tablets on the FDA's website (United States Food and Drug Administration).
The products contain traces of N-nitrosodiethylamine (NDEA), a substance found in certain foods, drinking water, air pollution and industrial processes and was classified as a probable human carcinogen according to the International Agency for Research on Cancer (IARC) classification.
Losartan is used to treat hypertension, hypertensive patients with left ventricular hypertrophy and for the treatment of cancer nephropathy in type 2 diabetics.
Patients who are on losartan should continue to take their medications, officials said, as the risk to the patient's health may be higher if treatment is discontinued immediately without alternative treatment.
Patients should contact their pharmacist or doctor, who may recommend alternative treatment before returning their medication.  Products affected by the recall are listed below and packaged in bottles. The product can be identified by checking the product name, manufacturer's instructions and batch or lot number on the bottle with these products.
WHAT OTHER CLICK ON:
>> MORE STORIES